Mahammed Raja *, Arshad Bashir Khan
- Department of Pharmaceutics, Krupanidhi College of Pharmacy, #12/1, Chikkabellandur, Carmelaram Post, Bangalore - 560035, India
Abstract
Purpose: The formulation and evaluation of hydrodynamically balanced tablets of ranitidine hydrochloride for gastric drug delivery was the specific aim of this research. Method: The hydrodynamically balanced tablets were prepared by direct compression technique with different ratios of polymers like hydroxyproylmethyl cellulose (HPMC K 4M), Ethyl cellulose, Xanthan gum and Guar gum. The prepared tablets were evaluated for their weight variation, hardness, drug content, friability, floating lag time, floating duration, in vitro dissolution and accelerated stability studies at 40�C � 2�C/75% RH � 5% for eight weeks. Conclusion: The floating tablets of ranitidine hydrochloride (HCl) were evaluated for physicochemical characteristics like hardness, weight variation, friability, floating lag time and stability studies. The in vitro buoyancy studies, in vitro drug release studies and the results showed that the best formulation. F2 had sustained release up to 98% of ranitidine hydrochloride over a period of 24 h.
References
- Yadav S K, Kavita K, Tamizhamani T. Formulation and evaluation of floating tablets of ranitidine hydrochloride using natural and synthetic polymers. Int J Pharm Tech Res. 2010; 2(2): 1513-1519.
- Histamine H2 antagonists. In: Drug facts and comparisons. St Louis, MO: Wolters Kluwer Co., 2002, 1192-1197.
- Lauritsen K. Clinical pharmacokinetics of drugs used in the treatment of gastro intestinal diseases.ClinPharmacokinet. 1990;19:11-31, 94-125.
- Basit A, Lacey L. Colonic metabolism of ranitidine: implications for its delivery and absorption. Int J Pharm. 2001; 227(1-2): 157-165.
- Pharmacopoeia of India, Vol 1, Ministry of Health and Family Welfare, Govt. of India, Controller of Publ., Delhi, (1996) p. 188.
- Pharmacopoeia of India. Vol 11, Ministry of Health and Family Welfare, Govt. of India, Controller of Publ., Delhi, (1996) p. A-82.
- ICH Q1A(R2). Stability testing guidelines : Stability testing of new drug substances and products. ICH Steering Committee, 2003.
- ICH Harmonised Tripartite Guideline. Stability testing: photostability testing of new drug substances and products Q1B. Geneva: ICH; 1996.
